A Study of the Safety, Tolerability and Pharmacokinetics of Orally-administered GC4702 in Healthy Volunteers

NCT03096756 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: GC4702 dry powder
DRUG: GC4702 lipid suspension
OTHER: GC4419 IV
OTHER: Placebo Dry Powder
OTHER: Placebo lipid suspension
OTHER: Fed Condition
OTHER: Fasting Condition
DRUG: GC4702 lipid suspension - Part 2

Sponsor

Galera Therapeutics, Inc.

Collaborators

[object Object]
[object Object]